01.06.2005 | Original Article
Randomized, open label, prospective study on the effect of zoledronic acid on the prevention of bone metastases in patients with recurrent solid tumors that did not present with bone metastases at baseline
Erschienen in: Medical Oncology | Ausgabe 2/2005
Einloggen, um Zugang zu erhalten